GlassScriptPhysician profile
Aditya Singh
NPI 1194270280
$36,500.83
in general payments reported to CMS, 2019-2025
31 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $209 · 2021: $4,006 · 2022: $6,715 · 2023: $8,646 · 2024: $4,875 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Travel and Lodging: $9,936 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,253.07 |
| Travel and Lodging | $9,935.67 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,736.40 | 2021-2025 | Corevalve Evolut R, Micra, Resolute Onyx |
| Abbott Laboratories | $5,885.04 | 2021-2025 | Mitraclip, Triclip, Cardiomems |
| Biotronik INC. | $2,854.69 | 2022-2025 | Orsiro Mission |
| Edwards Lifesciences Corporation | $1,942.00 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Hemosphere |
| Abiomed | $1,877.49 | 2023-2025 | Impella |
| Philips North America LLC | $1,389.87 | 2023-2025 | Coronary Other, Coronary Undivided, Intrasight 2 Integrated |
| Boston Scientific Corporation | $1,145.94 | 2022-2025 | Rotapro, Avvigo Guidance System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $612.00 | 2019-2023 | Lifevest |
| Acist Medical Systems, INC. | $483.00 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $312.44 | 2020-2022 | |
| Terumo Medical Corporation | $251.99 | 2022 | |
| Amgen INC. | $198.06 | 2019-2025 | Repatha |
| Heartflow, INC. | $190.88 | 2023 | Ffrct |
| Asahi Intecc USA, INC. | $187.34 | 2023-2024 | Asahi Ptca Guide Wire, Peripheral Vascular |
| Actelion Pharmaceuticals US, INC. | $154.81 | 2019-2025 | Uptravi, Opsumit |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $146.84 | 2022 | |
| Cvrx, INC. | $143.71 | 2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $130.31 | 2020-2025 | Camzyos, Eliquis |
| Siemens Medical Solutions USA, INC. | $125.29 | 2025 | Artis Icono Floor |
| Portola Pharmaceuticals, LLC | $102.74 | 2019 | |
| Pfizer INC. | $91.17 | 2023-2025 | |
| Shockwave Medical, INC | $70.04 | 2025 | |
| Novartis Pharmaceuticals Corporation | $69.60 | 2020-2024 | |
| Kiniksa Pharmaceuticals, LTD. | $69.30 | 2022 | |
| Impulse Dynamics (USA) INC. | $69.20 | 2024 | Optimizer |
| Bridgebio Pharma, INC. | $50.29 | 2025 | Attruby |
| Medtronic Vascular, INC. | $48.66 | 2019-2020 | |
| Amarin Pharma, INC. | $47.95 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $47.10 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $40.92 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $25.76 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aditya Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.